Endomag

About Endomag

Endomag is a pioneering medical technology company based in the UK, dedicated to improving cancer care through innovative solutions. Our flagship product, the Sentimag® system, is designed to enhance the accuracy of breast cancer surgeries by providing real-time guidance to surgeons. This technology allows for the precise identification of sentinel lymph nodes, significantly reducing the need for invasive procedures.

At Endomag, we believe in empowering healthcare professionals with tools that enhance patient outcomes. Our commitment to research and development drives us to continuously improve our products and expand our offerings. We collaborate closely with clinicians and researchers to ensure that our solutions meet the evolving needs of the medical community.

Our vision is to transform cancer surgery by making it less invasive and more effective. We aim to provide surgeons with the confidence they need to make informed decisions during procedures, ultimately leading to better recovery times and improved quality of life for patients.

Endomag is also committed to sustainability and ethical practices in all aspects of our operations. We strive to minimize our environmental impact while delivering high-quality medical devices that adhere to the highest standards of safety and efficacy.

With a growing team of dedicated professionals, Endomag is poised to make a significant impact in the field of oncology. We are proud to be at the forefront of medical innovation, and we look forward to continuing our mission of enhancing cancer care worldwide.